Health Care & Life Sciences » Pharmaceuticals | Clinuvel Pharmaceuticals Ltd.

Clinuvel Pharmaceuticals Ltd.

Clinuvel Pharmaceuticals Ltd.
Stock Exchange Other OTC
EPS
 $0.24
Market Cap
 $1.16 B
Shares Outstanding
 47.82 M
Public Float
 -
Clinuvel Pharmaceuticals Ltd. ADR
Stock Exchange Other OTC
EPS
 $0.24
Market Cap
 $1.14 B
Shares Outstanding
 48.96 M
Public Float
 -
Clinuvel Pharmaceuticals Ltd.
Stock Exchange Australian Stock Exchange
EPS
 AUD0.32
Market Cap
 AUD1.63 B
Shares Outstanding
 48.96 M
Public Float
 36.67 M
Clinuvel Pharmaceuticals Ltd.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 47.86 M
Public Float
 -

Profile

Address
15 Queen Street
Melbourne Victoria (VIC) 3000
Australia
Employees -
Website http://www.clinuvel.com
Updated 07/08/2019
Clinuvel Pharmaceuticals Ltd. is a global biopharmaceutical company. It engages in the the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders.

Financials

View All
Created with Highcharts 5.0.14Clinuvel Pharmaceuticals Ltd.Net Income. Fiscal year is July-June. All values AUD Thousands.5 5255 52510 41410 4143 1213 1217 1807 18013 22413 2242014201520162017201802.5k5k7.5k10k12.5k15k
Created with Highcharts 5.0.14Clinuvel Pharmaceuticals Ltd.Sales/Revenue. Fiscal year is July-June. All values AUD Thousands.2 2002 2002 9112 9116 2116 21116 72016 72025 48525 4852014201520162017201805k10k15k20k25k30k

Philippe J. Wolgen
Chief Executive Officer, MD & Director
Stanley R. McLiesh
Non-Executive Chairman
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.